AMD · ADVANCED MICRO DEVICES INC
10-Q filed 2026-05-06 period 2026-03-28
87 Strong
confidence high · source filing on SEC.gov ↗
- AMD entered into a major strategic amendment with Meta Platforms to deploy up to 6 gigawatts of AMD GPUs, issuing a milestone-based warrant for up to 160 million shares.
- Data Center segment revenue surged 57% year-over-year to $5.8 billion, driven by strong demand for 5th Gen EPYC processors and Instinct MI350 GPUs.
- Competitor dynamics intensified with Nvidia's September 2025 partnership and investment in Intel, posing potential pricing and market share risks.
Filing Health Score pillars
Profitability 25%
90
Revenue grew 38% YoY to $10.25 billion, and gross margin expanded by 300 bps to 53%, driving an 83% increase in operating income to $1.48 billion (MD&A - Gross Margin and Expenses).
Balance sheet 20%
85
AMD maintains a strong liquidity position with $12.3 billion in cash and short-term investments against $3.3 billion in total debt, and excellent interest coverage with $1.48 billion in operating income against $37 million in interest expense (MD&A - Financial Condition).
Cash generation 20%
92
Cash flow from operations of $2.96 billion significantly exceeded net income of $1.4 billion, and free cash flow reached approximately $2.57 billion after $389 million in capital expenditures, representing a strong 25% FCF margin (MD&A - Financial Condition).
Risk flags 20%
80
While controls are effective, risk flags include high customer concentration and a new competitive threat from a September 2025 partnership and investment between Nvidia and Intel (Risk Factors - Economic and Strategic Risks).
Mgmt signal 15%
88
Management signaled strong momentum with a 57% increase in Data Center revenue and a major strategic amendment with Meta to deploy up to 6 gigawatts of AMD GPUs (MD&A - Overview and Recent Developments).
Key metrics (Three months ended March 28, 2026)
net income: $1,400 million
cash and equivalents: $12.3 billion
total debt: $3.3 billion
shares outstanding: Not explicitly reported
revenue: $10,253 million
period: Three months ended March 28, 2026
operating cash flow: $2,955 million
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.